BG-12 (dimethyl fumarate) drug submitted to FDA March 2012

BG-12 provides about 50% reduction of MS relapses. Raising vitamin D by 20 ng provides about 50% reduction in MS relapses BG-12 is patented, so the company can charge a lot of money and make huge profits $3 billion annual revenue anticipated Bloomberg Nov 2011

Guess at the annual costs for similar 50% reduction in MS relapses

~hs~~hs~~hs~~hs~~hs~~hs~~hs~$10 Vitamin D: many POSITIVE side effects $10,000 BG-12: possible NEGATIVE side effects

See VitaminDWiki

• Overview of MS and Vitamin D
• Vitamin D for MS is becoming mainstream Blog Feb 2012
• 32% fewer MS lesions with just +10 ng of vitamin D
• MS Factoids with some relationships to Vitamin D